These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections.
    Author: Colgan R, Michocki R, Greisman L, Moore TA.
    Journal: Am Fam Physician; 2003 Feb 15; 67(4):763-6, 675. PubMed ID: 12613730.
    Abstract:
    Family physicians should be familiar with the various drugs available for treating and preventing viral infections. Part II of this two-part article focuses on agents used to manage influenza and respiratory syncytial virus. Rimantadine and amantadine traditionally have been used to prevent and treat influenza type A infections. The neuraminidase inhibitors zanamivir and oseltamivir have a broadened spectrum of activity in the treatment and prevention of influenza types A and B. Ribavirin has been used in some high-risk infants to treat respiratory syncytial virus infections, and palivizumab can be used for prophylaxis.
    [Abstract] [Full Text] [Related] [New Search]